Eight Bottles Set of Aged Premium Sake for 2.02 Million Yen! By the "Tokisake Association," Creating the Value of Aged Japanese Sake for the World. Online Reservation Commences on November 24 (Tuesday)
The Tokisake Association (located in Kyoto Prefecture, President, Tokubee Masuda) was established in August 2019 with the aim of reviving the culture of aged sake and establishing and further enhancing the value of sake to the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201120005313/en/
The new product "Toki no Shirabe" set (Photo: Business Wire)
The company will sell the highest-priced product in the history of Japanese sake, “Toki no Shirabe” in a limited edition of 20 sets of 8 bottles (720 ml) for 2,020,000 yen, for domestic and international customers to commemorate the establishment of the Association.
In addition to seven bottles of secret sake commercialized from each of the seven breweries that are the founding members of the Association, another very rare bottle is an assemblage (blend) by the world-renowned sommelier Mr. Shinya Tasaki, to complete a limited edition of eight bottles.
By releasing this ultra-gorgeous new product, which is a collection of excellent products engraved over the years, they will continue to contribute to the creation of even more value for Japanese sake in Japan and abroad.
[New Product Overview]
Product Name: [Special Limited] Aged sake set of 8 bottles of "Toki no Shirabe"
Price: 2.02 million yen
Booking period: November 24 (Tuesday) to December 5 (Saturday)
Pre-orders are accepted at: Shusaron.com (https://shusaron-online.com/shopdetail/000000000042/).
If the number of reservation requests exceeds 20, eligible purchasers will be selected by lottery. The set’s gift box is an original work of art by Yoshizawa Ryoichi, an artisan, and is “made of rice husks that are removed during the brewing process and finished with lacquer based on the shape of a traditional Japanese stacked box,” according to Yoshizawa.
[Limited release 8 bottles of sake]
- Masuda Tokubee Shoten Co., Ltd. / Kyoto: “Tsukino Katsura” 1999
- Kokuryu Sake Brewing Corporation / Fukui: Kokuryu "Muni" Junmai Daiginjo Genshu 1996
- DEWAZAKURA SAKE BREWERY CO.,LTD / Yamagata: "Dewazakura Daiginjo Daikoshu cold aged” 1990 & 1986
- Nanbu Bijin Co., Ltd. / Iwate: "Nanbu Bijin All Koji" Junmai 1998
- Shimazaki Shuzo Co., Ltd. / Tochigi: "Azumarikishi Uroko" Daiginjo Genshu 1987
- NAGAI SAKE INC. / Gunma: “Mizubasho Shizuku Daiginjo ice aged" 2003
- Kidoizumi Shuzo Co., Ltd. / Chiba: "Kidoizumi Afs" Yamahai Junmai 1984
- Mr. Shinya Tasaki's assemblage blend, "Toki no Shirabe”
https://www.youtube.com/watch?v=B18SYRjMA8c
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201120005313/en/
Contact information
The Tokisake Association
PR: Tomoko Takiguchi
Email: info@greencreate.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Geoquip Marine Secures €100million Bond to Accelerate Fleet Enhancements and Strategic Growth4.4.2025 10:00:00 EEST | Press release
Geoquip Marine (Geoquip), a global leader in offshore geotechnical solutions and a Njord Partners portfolio company, is pleased to announce today it has successfully closed a €100million bond offering. This bond issuance significantly improves the Company’s cash balance, supports its continued growth, and is seen as a significant step in the Company’s ongoing maturation and development. The bond was placed after a successful roadshow with investors and will be used to advance key strategic initiatives. The immediate use of proceeds will be allocated between the repayment of existing debt and funding for two transformational projects: The Geoquip Silvretta: As announced in December, Geoquip Silvretta is currently in a shipyard in Norway undergoing work to create a state-of-the-art geotechnical services platform for the offshore energy sector. The vessel is on track to start operations in the first half of 2025. The Geoquip Elena: The Company is preparing to install a rig on Geoquip Elen
SES Announces Annual General Meeting Voting Results4.4.2025 09:50:00 EEST | Press release
SES S.A. (“SES” or the “Company”) held the Company’s Annual General Meeting (“AGM”) at its headquarters in Betzdorf, Luxembourg, yesterday. The shareholders have voted all resolutions in accordance with the recommendations made by SES’s Board of Directors, notably the company’s 2024 annual accounts and the proposed annual dividend of EUR 0.50 per A-share (EUR 0.20 per B-share). The total amount includes the interim dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) already paid to shareholders on 17 October 2024. The final dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) will be paid to shareholders on 17 April 2025. Also as recommended by the Board of Directors, the shareholders approved the appointments of Mrs Ellen Lord and Mr John Shaw to the Board of Directors and the non-binding agenda item received from Atlas Infrastructure Partners regarding capital returns. “The outcome of the AGM is the result of SES’s ongoing commitment to productive shareholder engagement, ensur
ENHERTU ® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy4.4.2025 09:00:00 EEST | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 low (IHC 1+ or IHC 2+/ISH-) or HER2 ultralow (IHC 0 with membrane staining) breast cancer who have received at least one endocrine therapy in the metastatic setting and who are not considered suitable for endocrine therapy as the next line of treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca. The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the DESTINY-Breast06 phase 3 trial presented at the 2024 American Society of Clinical Oncology (#
Western Union Offers Zero-Fee International Money Transfers to Myanmar4.4.2025 04:00:00 EEST | Press release
In response to the devastating earthquake that recently struck Myanmar, Western Union today announced that it is offering consumers around the world zero-fee international money transfers1 to the country. Effective immediately until midnight, 00:00 Myanmar Standard Time on 10 April 2025, individuals can send funds to Myanmar via WesternUnion.com or the Western Union mobile app, ensuring families can provide crucial support to their loved ones during this time of urgent need. Western Union remains committed to providing support during times of crisis, offering zero-fee transfers whenever possible to help communities in need. Money transfers sent to Myanmar will be: Available for payout into bank accounts. Available for payout into select mobile wallets Available for payouts incash at Agent locations2 “Our thoughts are with the people of Myanmar during this incredibly difficult time,” said Atish Shrestha, Western Union’s Regional Director for Indochina, South Korea and Taiwan, Western Un
Clean Tech Leader Aymium Defeats Stora Enso at European Patent Office Boards of Appeal4.4.2025 01:07:00 EEST | Press release
Cleantech leader Aymium defeated a challenge by Stora Enso to one of Aymium's patents (European Patent EP2697185) that provides exclusive rights to produce, sell and use bio-based materials for renewable battery applications. In its written opinion, the Boards of Appeal of the European Patent Office found Stora Enso's arguments brought before the board “not convincing” and agreed that a clarifying amendment to the claims did not extend the scope of protection of the patent. The ruling further affirms Aymium's position as the global leader in biocarbon materials for battery applications. Beyond the present ruling, Aymium owns a portfolio of more than 600 patents relating to biocarbon materials, compositions and manufacturing methods, including many specifically relevant to battery materials, and is the dominant global innovator regarding biocarbon materials. The ruling, combined with Aymium's massive patent portfolio, calls into question the ability of Stora Enso to produce bio-based ba
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom